KALEIDO BIOSCIENCES INC (KLDO)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

The biggest pre-market stock movers for Thursday are ready and waiting so let's see what's moving the market this morning!

Why Is Creatd (CRTD) Stock Up Today?

Creatd (CRTD) stock is heading higher on Wednesday following news of a deal for wellness beverage subsidiary Dune Glow Remedy.

Dear KLDO Stock Fans, Mark Your Calendars for April 28

Kaleido Biosciences (KLDO) stock is soaring on Wednesday but anyone considering a stake in the company will want to keep an eye on April 28.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!

Monday Sector Laggards: Shipping, Biotechnology Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Rise and shine, investor! It's time to start off another week of trading with the biggest pre-market stock movers for Monday!

Friday Sector Laggards: Biotechnology, Semiconductors

Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies for 2022

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, has been named to Fast Company's prestigious annual list of the World's Most...

Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology

/PRNewswire/ -- Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent and tunable medicines, has appointed Stuart Milstein,...

Flagship Pioneering Announces Appointment of Tom DiLenge as Senior Partner, Global Public Policy, Regulatory & Governmental Strategy

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that Tom DiLenge has joined the company in a newly created role as...

Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis Congress

LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated,...

Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions

LEXINGTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated,...

Flagship Pioneering Announces Appointment of Justine Levin-Allerhand as Senior Partner, Corporate Development

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that Justine Levin-Allerhand, Ph.D., has joined the company in a newly...

Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer

LEXINGTON, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated,...

Kaleido Biosciences Reports Third Quarter 2021 Financial Results

--Achieved primary objective of safety and tolerability in clinical study evaluating KB295 in mild-to-moderate ulcerative colitis; meaningful reduction...

Down 23.6% in 4 Weeks, Here's Why Kaleido Biosciences, Inc. (KLDO) Looks Ripe for a Turnaround

Kaleido Biosciences, Inc. (KLDO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.